samedan logo

 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

SPT Labtech acquires BioMicroLab

SPT Labtech

Deal strategically expands SPT Labtech’s offering in sample management for life sciences


Cambridge, UK – 16 February 2021 – SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, announces the acquisition of BioMicroLab, a robotics automation provider for life science laboratories.

Headquartered in Northern California, BioMicroLab designs and manufactures laboratory automation equipment for biotechnology and scientific research. BioMicroLab's extensive range of sample handling and tracking solutions complements SPT Labtech's capabilities in modular, automated sample storage systems and expands its product breadth in the sample management market.

Patrick Bennett, Group CEO at SPT Labtech, said, "Over the last 25 years, BioMicroLab has established a well-deserved reputation as a dependable partner for intuitive and reliable benchtop automation. This important investment delivers significant benefits to customers by creating a powerful end-to-end solution to streamline sample management workflows. We are delighted to welcome BioMicroLab to SPT Labtech."

David Miller, President of BioMicroLab, said, "SPT Labtech has an impressive track record of harnessing innovation to overcome tough research challenges and deep expertise across a range of life sciences applications. We are confident that customers will benefit from our combined capabilities and look forward to continuing to enable their research success as part of the SPT Labtech team."

The deal follows SPT Labtech’s recent acquisition of Apricot Designs, a liquid handling technology provider, and underscores its commitment to creating powerful automated solutions to accelerate life science research.

phone +44 (0)1223 627555
email discover@sptlabtech.com
web www.sptlabtech.com
email SPT Labtech Ltd. Melbourn Science Park Melbourn Hertfordshire SG8 6HB United Kingdom
 
Print this page
Send to a friend
   
spacer
News and Press Releases

EQRx Scales Disruptive Model of Important New Medicines at Lower Prices with $500M Series B Financing

Funding accelerates development of late-stage cancer therapies, pipeline expansion and business growth Syndicate includes all Series A investors, preeminent life science and generalist funds, and market-leading health systems and payers
More info >>


White Papers

Maximize the ROI of Your Post-Approval Research

Bioclinica

Expenditures in post-approval (Phase IV) research are going up across the pharmaceutical, biotech and medical device industries. Given the resources you’ve committed to post-approval research, you may be wondering if you’re getting the greatest possible return on your investment. Discover how to harness the power of post-approval research to increase data collection, reduce resource burn, save money, and maximize your ROI!
More info >>

Industry Events

DIA Europe 2021

15-19 March 2021, VIRTUAL CONFERENCE

DIA Europe is the must-attend event for all life science professionals working in drug development, from discovery to marketed use. It encourages open collaboration by bringing together representatives from the entire spectrum of the life science landscape and facilitating crucial discussions across several topic tracks: Clinical Development, Regulatory Strategy, Pharmacovigilance, Value and Access, Health Policy, and many more.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement